دورية أكاديمية
Can a biobank network and supporting infrastructure enhance Ireland's ability to attract pharmaceutical research and development and clinical trial opportunities? A pilot survey
| العنوان: | Can a biobank network and supporting infrastructure enhance Ireland's ability to attract pharmaceutical research and development and clinical trial opportunities? A pilot survey |
|---|---|
| المؤلفون: | Mee,Blanaid, Gaffney,Eoin, McGarrigle,Sarah, Glynn,Sharon, Connolly,Elisabeth, McCormick,Paul, Flannery,Delia, O'Connor,Katrina, Lawson,Margaret, Ryan,Lisa, Nugent,Timothy, Ward,Ronan, Sullivan,Francis J, Fay,Joanna, O'Grady,Tony, Kay,Elaine, Eustace,Joe, Burke,Louise, Finn,Stephen, Flavin,Richard |
| بيانات النشر: | Dove Press |
| سنة النشر: | 2016 |
| المجموعة: | Dove Medical Press |
| مصطلحات موضوعية: | Journal of Biorepository Science for Applied Medicine |
| الوصف: | Blanaid Mee,1 Eoin Gaffney,2,3 Sarah McGarrigle,4 Sharon A Glynn,5,6 Elisabeth M Connolly,7 Paul H McCormick,7 Delia Flannery,7 Katrina O'Connor,7 Margaret Lawson,1 Lisa Ryan,1 Timothy Nugent,1 Ronan Ward,1 Francis J Sullivan,6 Joanna Fay,8 Tony O'Grady,8 Elaine Kay,8 Joe Eustace,9 Louise Burke,9 Stephen Finn,1 Richard Flavin1 1Department of Pathology, St James's Hospital, 2Trinity College Dublin, Dublin, 3National University of Ireland Galway, Galway, 4Department of Surgery, School of Medicine, Faculty of Health Sciences, Trinity College Dublin, Dublin, 5Department of Pathology, National University of Ireland Galway, 6Prostate Cancer Institute, National University of Ireland Galway, Galway, 7Department of Surgery, St James's Hospital, 8Department of Pathology, Beaumont Hospital, Dublin, 9Department of Pathology, Cork University Hospital, Cork, IrelandAbstract: Ireland has an established reputation in specialized global pharmaceutical manufacturing. However, simple high-volume manufacturing will not sustain the Irish pharmaceutical industry, and government agencies recommend a greater focus on innovation and research and development (R&D). Biobank Ireland Trust sought the views of the Irish pharmaceutical industry on the potential benefits of a national biobank network (NBN), national biobank web portal (NBWP), and center for translational molecular oncologic pathology (CTOP). Questionnaires were sent to 19 companies and eleven responded. Questionnaire A was completed by six companies presently engaged in R&D in Ireland – three pharmaceutical companies, two spin outs, and one contract research organization. Six of six respondents reported that: a NBN would benefit their company; the development of a NBWP was important; and finally, they forecast that the requirement for biobanked material would continue to increase. While three of six predicted that a NBN would facilitate an expansion of current R&D activities. The relative importance of accessing biobanked material and data varied. An associated ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | text/html |
| اللغة: | English |
| العلاقة: | https://www.dovepress.com/can-a-biobank-network-and-supporting-infrastructure-enhance-irelandati-peer-reviewed-fulltext-article-BSAMTest |
| الإتاحة: | https://doi.org/10.2147/BSAM.S103837Test https://www.dovepress.com/can-a-biobank-network-and-supporting-infrastructure-enhance-irelandati-peer-reviewed-fulltext-article-BSAMTest |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.3DA174DE |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |